1
|
Marty B, Naeije G, Bourguignon M, Wens V, Jousmäki V, Lynch DR, Gaetz W, Goldman S, Hari R, Pandolfo M, De Tiège X. Evidence for genetically determined degeneration of proprioceptive tracts in Friedreich ataxia. Neurology 2019; 93:e116-e124. [PMID: 31197032 DOI: 10.1212/wnl.0000000000007750] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Accepted: 02/25/2019] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To assess with magnetoencephalography the developmental vs progressive character of the impairment of spinocortical proprioceptive pathways in Friedreich ataxia (FRDA). METHODS Neuromagnetic signals were recorded from 16 right-handed patients with FRDA (9 female patients, mean age 27 years, mean Scale for the Assessment and Rating Of ataxia [SARA] score 22.25) and matched healthy controls while they performed right finger movements either actively or passively. The coupling between movement kinematics (i.e., acceleration) and neuromagnetic signals was assessed by the use of coherence at sensor and source levels. Such coupling, that is, the corticokinematic coherence (CKC), specifically indexes proprioceptive afferent inputs to the contralateral primary sensorimotor (cSM1) cortex. Nonparametric permutations and Spearman rank correlation test were used for statistics. RESULTS In both groups of participants and movement conditions, significant coupling peaked at the cSM1 cortex. Coherence levels were 70% to 75% lower in patients with FRDA than in healthy controls in both movement conditions. In patients with FRDA, coherence levels correlated with genotype alteration (i.e., the size of GAA1 triplet expansion) and the age at symptom onset but not with disease duration or SARA score. CONCLUSION This study provides electrophysiologic evidence demonstrating that proprioceptive impairment in FRDA is mostly genetically determined and scarcely progressive after symptom onset. It also positions CKC as a reliable, robust, specific marker of proprioceptive impairment in FRDA.
Collapse
Affiliation(s)
- Brice Marty
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Gilles Naeije
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland.
| | - Mathieu Bourguignon
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Vincent Wens
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Veikko Jousmäki
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - David R Lynch
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - William Gaetz
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Serge Goldman
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Riitta Hari
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Massimo Pandolfo
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| | - Xavier De Tiège
- From the Laboratoire de Cartographie Fonctionnelle du Cerveau (B.M., G.N., M.B., V.W., S.G., X.D.T.) and Laboratoire Cognition Langage et Développement (M.B.), ULB Neuroscience Institute, and Department of Neurology (G.N., M.P.) and Department of Functional Neuroimaging (V.W., X.D.T., S.G.), Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium; Basque Center on Cognition, Brain and Language (M.B.), Donostia, Spain; Department of Neuroscience and Biomedical Engineering (V.J.), School of Science, Aalto University, Espoo, Finland; Children's Hospital of Philadelphia (D.R.L., W.G.), PA; and Department of Art (R.H.), Aalto University, Helsinki, Finland
| |
Collapse
|